FederalDC
Posted
Sep 22, 2026
Mar 22, 2027
TECHNOLOGY LICENSING OPPORTUNITY: SignalGen
The Department of Energy, through Los Alamos National Laboratory, is offering SignalGen, a generative-AI platform that predicts signal peptides for specific proteins. The technology is patent pending and is intended for applications including therapeutic protein development, vaccine research, drug discovery, biomanufacturing, and protein engineering. This is a technology licensing opportunity offering exclusive and non-exclusive licensing agreements, not a call for external development or service contracts.
